Arvind Arora

Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer

IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

Cancer nanomedicine: progress, challenges and opportunities

Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

The immune contexture in cancer prognosis and treatment

Inflammation and tumor progression: signaling pathways and targeted intervention

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

DNA repair pathways and cisplatin resistance: an intimate relationship

Cisplatin: The first metal based anticancer drug

ROS and the DNA damage response in cancer

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Lessons from patient-derived xenografts for better in vitro modeling of human cancer

Targeting DNA‐Dependent Protein Kinase for Cancer Therapy

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies

Simultaneous precise editing of multiple genes in human cells

Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT–YB1–MDR1 Signaling Pathway

The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays

Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers

5-Carboxylcytosine levels are elevated in human breast cancers and gliomas

Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy

ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.